AMERIPRISE FINANCIAL INC - EATON VANCE SH TM DR DIVR IN ownership

EATON VANCE SH TM DR DIVR IN's ticker is EVG and the CUSIP is 27828V104. A total of 46 filers reported holding EATON VANCE SH TM DR DIVR IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of EATON VANCE SH TM DR DIVR IN
ValueSharesWeighting
Q3 2023$2,292,334
+385.7%
221,054
+359.5%
0.00%
Q2 2023$471,922
+9.3%
48,106
+16.4%
0.00%
Q1 2023$431,820
+6.9%
41,322
+4.1%
0.00%
Q4 2022$404,000
+48.0%
39,684
+42.7%
0.00%
Q3 2022$273,000
+19.2%
27,809
+30.7%
0.00%
Q2 2022$229,000
-53.5%
21,272
-50.1%
0.00%
Q1 2022$493,000
-1.2%
42,621
+13.3%
0.00%
Q4 2021$499,000
+84.8%
37,616
+85.8%
0.00%
Q3 2021$270,000
-8.8%
20,244
-7.7%
0.00%
Q4 2019$296,000
-26.4%
21,928
-28.2%
0.00%
Q3 2019$402,000
-0.5%
30,539
+2.5%
0.00%
Q2 2019$404,000
+11.0%
29,803
+6.3%
0.00%
Q1 2019$364,000
+4.3%
28,046
+0.1%
0.00%
Q4 2018$349,000
+7.7%
28,031
+11.7%
0.00%
Q3 2018$324,000
-10.2%
25,092
-9.5%
0.00%
Q2 2018$361,000
-4.5%
27,722
-0.1%
0.00%
Q1 2018$378,000
-10.4%
27,740
-5.6%
0.00%
Q4 2017$422,000
-6.0%
29,375
-6.9%
0.00%
Q3 2017$449,000
+49.7%
31,563
+47.8%
0.00%
Q2 2017$300,000
-39.5%
21,362
-39.2%
0.00%
Q1 2017$496,000
-36.6%
35,131
-30.4%
0.00%
-100.0%
Q3 2013$782,000
+12.2%
50,460
+17.1%
0.00%
Q2 2013$697,00043,1020.00%
Other shareholders
EATON VANCE SH TM DR DIVR IN shareholders Q3 2023
NameSharesValueWeighting ↓
SIT INVESTMENT ASSOCIATES INC 7,092,985$87,669,0002.37%
Relative Value Partners Group, LLC 1,553,212$19,198,0001.82%
Thomas J. Herzfeld Advisors, Inc. 93,001$1,149,0000.54%
MARINER INVESTMENT GROUP LLC 14,700$182,0000.37%
STRATEGIC CAPITAL ADVISERS, INC. 33,900$419,0000.36%
Shaker Financial Services, LLC 43,632$539,0000.22%
Pointe Capital Management LLC 16,184$200,0000.17%
Winning Points Advisors, LLC 11,000$135,960,0000.11%
Bulldog Investors, LLP 21,402$265,0000.10%
BOOTHBAY FUND MANAGEMENT, LLC 144,910$1,791,0000.07%
View complete list of EATON VANCE SH TM DR DIVR IN shareholders